Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Non-LDL Lipid Lowering Targets for Event Reduction May 13, 2022 Disclosures: TBA
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Reimagining Prevention from a Public Healthcare Perspective May 12, 2022 Disclosures: TBA
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: The Verve Therapeutics Gene Editing Approach to Lowering LDL in Familial Hypercholesterolemia May 10, 2022 Disclosures: TBA
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Secondary Analysis Of The CANTOS Trial: Differential Impact Of Residual Inflammatory Risk And Residual Cholesterol Risk Among Atherosclerosis Patients With And Without Chronic Kidney Disease April 4, 2022 Disclosures: TBA
Dr. Felix Mahfoud and Dr. C. Michael Gibson Discuss: 3-year Efficacy Outcomes From The Spyral Htn-on Med Pilot Study: Long Term Effect Of Renal Denervation On Blood Pressure Reduction In Patients On Antihypertension Medications April 4, 2022 Disclosures: TBA
Dr. Mehdi Shishehbor and Dr. Serge Korjian Discuss: A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions April 4, 2022 Disclosures: TBA
Dr. Marie-Sophie De Koning and Dr. C. Michael Gibson Discuss: GIPS-IV: The Groningen Intervention Study For The Preservation Of Cardiac Function With Sodium Thiosulfate After St-segment Elevation Myocardial Infarction April 4, 2022 Disclosures: TBA
Dr. Bon-Kwon Koo and Dr. C. Michael Gibson Discuss: The FLAVOUR Randomized Clinical Trial: Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis April 4, 2022 Disclosures: TBA
Dr. Duk-Woo Park and Dr. C. Michael Gibson Discuss: A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement April 4, 2022 Disclosures: TBA
Dr. Michael Reardon and Dr. Yazan Daaboul Discuss: Insights From The Corevalve US Pivotal And SURTAVI Trials: Five-year Incidence, Timing And Predictors Of Hemodynamic Valve Deterioration Of Transcatheter And Surgical Aortic Bioprostheses April 4, 2022 Disclosures: TBA
